Metabolomic Analysis of Plasma from Breast Cancer Patients Using Ultra-High-Performance Liquid Chromatography Coupled with Mass Spectrometry: An Untargeted Study

Breast cancer (BC) is one of the leading causes of cancer mortality in women worldwide, and therefore, novel biomarkers for early disease detection are critically needed. We performed herein an untargeted plasma metabolomic profiling of 55 BC patients and 55 healthy controls (HC) using ultra-high pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Da Cunha, Patricia A., Nitusca, Diana, Canto, Luisa Matos Do, Varghese, Rency S., Ressom, Habtom W., Willey, Shawna, Marian, Catalin, Haddad, Bassem R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147455/
https://www.ncbi.nlm.nih.gov/pubmed/35629952
http://dx.doi.org/10.3390/metabo12050447

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147455/
https://www.ncbi.nlm.nih.gov/pubmed/35629952
http://dx.doi.org/10.3390/metabo12050447

Ejemplares similares